Moxifloxacin Side Effects
|
|
Did You Have a Moxifloxacin Side Effect? How Effective is Moxifloxacin for You? |
Showing 1-25 of 655 Next Page >
Hypersensitivity, Dizziness (8480789-5)
on Jun 26, 2012 Female patient from UNITED STATES , 71 years of age, weighting 185.0 lb, was diagnosed with
Deep Vein Thrombosis (8455076-1)
Patient was taking Moxifloxacin (View Usage). Patient had the following side effects: deep vein thrombosis (deep vein thrombosis Questions) on Jun 08, 2012 from UNITED STATES Additional patient health information: Male patient , 62 years of age, weighting 183.6 lb, . Moxifloxacin dosage: Unk. Patient was hospitalized.
Dyspnoea, Anaphylactic Shock, Anosmia, Urticaria (8448468-8)
Adverse event was reported on Jun 13, 2012 by a Female patient taking Moxifloxacin Hcl (View Usage) (Dosage: 400 Unk, Unk) was diagnosed with
Hepatic Enzyme Increased (8448163-5)
on Jun 08, 2012 Male patient from SOUTH AFRICA , 32 years of age, weighting 136.7 lb, was treated with Moxifloxacin (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic enzyme increased. Moxifloxacin dosage: Unk.
Patient was taking other medications:
Cerebral Thrombosis, Pyrexia, Nausea, Abdominal Pain, Candidiasis, Herpes Zoster, Methaemoglobinaemia, Toxicity To Various Agents, Bacterial Sepsis (8434890-2)
on May 30, 2012 Male patient from AUSTRIA , 21 years of age, was diagnosed with
Patient was taking other medications:
Cytolytic Hepatitis, Haemolytic Anaemia, Haemodialysis, Disseminated Intravascular Coagulation, Hepatic Failure, Renal Failure Acute (8413697-6)
Patient was taking Moxifloxacin Hcl (View Usage). After Moxifloxacin was administered, patient had the following side effects: cytolytic hepatitis, haemolytic anaemia, haemodialysis, disseminated intravascular coagulation, hepatic failure, renal failure acute on May 30, 2012 from FRANCE Additional patient health information: Female patient , 34 years of age, . Moxifloxacin Hcl dosage: 400 Mg, Unk.
Patient was taking other medications:
Crying, Wheezing (8402843-6)
Adverse event was reported on May 31, 2012 by a Female patient taking Moxifloxacin (View Usage) (Dosage: N/A) . Location: SINGAPORE , 36 years of age, Patient experienced the following unwanted or unexpected effects: crying, wheezing.
Supraventricular Tachycardia, Neoplasm Malignant, Nodal Arrhythmia, Troponin Increased, Small Intestinal Obstruction, Aspiration, Pleural Effusion (8389281-X)
on May 17, 2012 Male patient from UNITED STATES , 69 years of age, weighting 163.1 lb, was treated with Moxifloxacin (View Usage). Patient had the following side effects: supraventricular tachycardia, neoplasm malignant, nodal arrhythmia, troponin increased, small intestinal obstruction, aspiration, pleural effusion. Moxifloxacin dosage: N/A.
Patient was taking other medications:
Rash, Skin Disorder (8388227-8)
on May 22, 2012 Male patient from BRAZIL , 60 years of age, was diagnosed with
Pulmonary Eosinophilia, Weight Decreased, Chest Pain, Pyrexia (8386962-9)
Patient was taking Moxifloxacin (View Usage). Patient experienced the following unwanted or unexpected effects: pulmonary eosinophilia, weight decreased, chest pain (chest pain Questions), pyrexia on May 24, 2012 from UNITED KINGDOM Additional patient health information: Male patient , 27 years of age, weighting 141.1 lb, was diagnosed with
Small Intestinal Obstruction, Diarrhoea, Condition Aggravated (8379103-5)
Adverse event was reported on May 22, 2012 by a Male patient taking Moxifloxacin (View Usage) (Dosage: 400 Mg Every Day Po) was diagnosed with
Bone Marrow Failure, Leukopenia (8359463-1)
on May 14, 2012 Male patient from UNITED STATES , 65 years of age, weighting 185.6 lb, was diagnosed with
Hypoacusis (8352962-8)
on May 09, 2012 Male patient from FRANCE , 40 years of age, was diagnosed with
Patient was taking other medications:
Hyperglycaemia (8336796-6)
Patient was taking Moxifloxacin (View Usage). Patient had the following side effects: hyperglycaemia on Apr 24, 2012 from SPAIN Additional patient health information: Male patient , 43 years of age, . Moxifloxacin dosage: N/A.
Patient was taking other medications:
Ear Infection, Clostridium Difficile Colitis (8322488-6)
Adverse event was reported on Apr 12, 2012 by a Female patient taking Moxifloxacin (View Usage) (Dosage: N/A) was diagnosed with
Patient was taking other medications:
Cognitive Disorder, Hallucination, Visual, Confusional State (8320714-0)
on Apr 26, 2012 Female patient from SPAIN , 85 years of age, was treated with Moxifloxacin (View Usage). Patient experienced the following unwanted or unexpected effects: cognitive disorder, hallucination, visual, confusional state. Moxifloxacin dosage: Unk.
Visual Acuity Reduced (8318000-8)
on Apr 17, 2012 Female patient from SOUTH AFRICA , weighting 85.10 lb, was diagnosed with
Patient was taking other medications:
Torsade De Pointes, Hypokalaemia, Hypomagnesaemia (8310020-2)
Patient was taking Moxifloxacin Hcl (View Usage). After Moxifloxacin was administered, patient had the following side effects: torsade de pointes, hypokalaemia, hypomagnesaemia on Apr 11, 2012 from CANADA Additional patient health information: Male patient , 22 years of age, . Moxifloxacin Hcl dosage: N/A.
Patient was taking other medications:
Clostridium Difficile Colitis, Fall, Ear Infection, Ligament Rupture, Meniscus Lesion (8301828-8)
Adverse event was reported on Apr 05, 2012 by a Female patient taking Moxifloxacin (View Usage) (Dosage: N/A) was diagnosed with
Patient was taking other medications:
Hepatotoxicity, Hepatic Fibrosis, Hepatitis Cholestatic, Pancreatic Duct Dilatation (8299343-3)
on Apr 16, 2012 Female patient from UNITED STATES , 46 years of age, was treated with Moxifloxacin (View Usage). Patient had the following side effects: hepatotoxicity, hepatic fibrosis, hepatitis cholestatic, pancreatic duct dilatation. Moxifloxacin dosage: N/A.
Electrocardiogram Qt Prolonged, Torsade De Pointes (8272288-0)
on Mar 26, 2012 Female patient from CANADA , 61 years of age, was treated with Moxifloxacin(View Usage). After Moxifloxacin was administered, patient had the following side effects: electrocardiogram qt prolonged, torsade de pointes. Moxifloxacin dosage: Unk.
Patient was taking other medications:
Ventricular Arrhythmia, Hypokalaemia, Torsade De Pointes (8270433-4)
Patient was taking Moxifloxacin Hcl (View Usage). Patient experienced the following unwanted or unexpected effects: ventricular arrhythmia, hypokalaemia, torsade de pointes on Mar 24, 2012 from CANADA Additional patient health information: Female patient , 61 years of age, . Moxifloxacin Hcl dosage: N/A.
Patient was taking other medications:
Torsade De Pointes, Blood Potassium Decreased, Electrocardiogram Qt Prolonged (8264721-5)
Adverse event was reported on Mar 26, 2012 by a Female patient taking Moxifloxacin (View Usage) (Dosage: N/A) . Location: ARGENTINA , 61 years of age, Patient had the following side effects: torsade de pointes, blood potassium decreased, electrocardiogram qt prolonged.
Patient was taking other medications:
Endocarditis (8260481-2)
on Feb 16, 2012 Female patient from BELGIUM , 43 years of age, was diagnosed with
Endophthalmitis, Iritis, Uveitis, Iridocyclitis, Vitritis, Retinal Haemorrhage (8248068-9)
on Mar 19, 2012 Male patient from JAPAN , 62 years of age, weighting 110.2 lb, was treated with Moxifloxacin Hydrochloride(View Usage). Patient experienced the following unwanted or unexpected effects: endophthalmitis, iritis, uveitis, iridocyclitis, vitritis, retinal haemorrhage. Moxifloxacin Hydrochloride dosage: N/A.
Patient was taking other medications:
on Jun 26, 2012 Female patient from UNITED STATES , 71 years of age, weighting 185.0 lb, was diagnosed with
- infection (infection Questions)
- pneumonia (pneumonia Questions)
Deep Vein Thrombosis (8455076-1)
Patient was taking Moxifloxacin (View Usage). Patient had the following side effects: deep vein thrombosis (deep vein thrombosis Questions) on Jun 08, 2012 from UNITED STATES Additional patient health information: Male patient , 62 years of age, weighting 183.6 lb, . Moxifloxacin dosage: Unk. Patient was hospitalized.
Dyspnoea, Anaphylactic Shock, Anosmia, Urticaria (8448468-8)
Adverse event was reported on Jun 13, 2012 by a Female patient taking Moxifloxacin Hcl (View Usage) (Dosage: 400 Unk, Unk) was diagnosed with
- oropharyngeal pain
Hepatic Enzyme Increased (8448163-5)
on Jun 08, 2012 Male patient from SOUTH AFRICA , 32 years of age, weighting 136.7 lb, was treated with Moxifloxacin (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic enzyme increased. Moxifloxacin dosage: Unk.
Patient was taking other medications:
- GLICLAZIDE (80 Mg, Bid) (View Gliclazide Review and Gliclazide Label )
- KANAMYCIN (1 G, Qd) (View Kanamycin Review and Kanamycin Label )
- ETHIONAMIDE (750 Mg, Qd) (View Ethionamide Review and Ethionamide Label )
- METFORMIN HCL (1 G, Bid) (View Metformin Hcl Review and Metformin Hcl Label )
Cerebral Thrombosis, Pyrexia, Nausea, Abdominal Pain, Candidiasis, Herpes Zoster, Methaemoglobinaemia, Toxicity To Various Agents, Bacterial Sepsis (8434890-2)
on May 30, 2012 Male patient from AUSTRIA , 21 years of age, was diagnosed with
- pyrexia
Patient was taking other medications:
- CLINDAMYCIN (900 Mg, 1 In 8 Min, Intravenous (not Otherwise Specified)) (View Clindamycin Review and Clindamycin Label )
Cytolytic Hepatitis, Haemolytic Anaemia, Haemodialysis, Disseminated Intravascular Coagulation, Hepatic Failure, Renal Failure Acute (8413697-6)
Patient was taking Moxifloxacin Hcl (View Usage). After Moxifloxacin was administered, patient had the following side effects: cytolytic hepatitis, haemolytic anaemia, haemodialysis, disseminated intravascular coagulation, hepatic failure, renal failure acute on May 30, 2012 from FRANCE Additional patient health information: Female patient , 34 years of age, . Moxifloxacin Hcl dosage: 400 Mg, Unk.
Patient was taking other medications:
- FLAGYL (Unk) (View Flagyl Review and Flagyl Label )
- OXYNORM (View Oxynorm Review and Oxynorm Label )
- DAPSONE (View Dapsone Review and Dapsone Label )
- POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label )
- SOPHIDONE (View Sophidone Review and Sophidone Label )
- CYMBALTA (60 Mg, Unk) (View Cymbalta Review and Cymbalta Label )
- NEURONTIN (600 Mg, Unk) (View Neurontin Review and Neurontin Label )
- RIFADIN (600 Mg, Unk) (View Rifadin Review and Rifadin Label )
Crying, Wheezing (8402843-6)
Adverse event was reported on May 31, 2012 by a Female patient taking Moxifloxacin (View Usage) (Dosage: N/A) . Location: SINGAPORE , 36 years of age, Patient experienced the following unwanted or unexpected effects: crying, wheezing.
Supraventricular Tachycardia, Neoplasm Malignant, Nodal Arrhythmia, Troponin Increased, Small Intestinal Obstruction, Aspiration, Pleural Effusion (8389281-X)
on May 17, 2012 Male patient from UNITED STATES , 69 years of age, weighting 163.1 lb, was treated with Moxifloxacin (View Usage). Patient had the following side effects: supraventricular tachycardia, neoplasm malignant, nodal arrhythmia, troponin increased, small intestinal obstruction, aspiration, pleural effusion. Moxifloxacin dosage: N/A.
Patient was taking other medications:
- PROCHLORPERAZINE (Ongoing) (View Prochlorperazine Review and Prochlorperazine Label )
- LORATADINE (Ongoing) (View Loratadine Review and Loratadine Label )
- ALBUTEROL (View Albuterol Review and Albuterol Label )
- LORAZEPAM (View Lorazepam Review and Lorazepam Label )
- PEMETREXED DISODIUM (View Pemetrexed Disodium Review and Pemetrexed Disodium Label )
- VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label )
- MORPHINE (View Morphine Review and Morphine Label )
- ASPIRIN (View Aspirin Review and Aspirin Label )
Rash, Skin Disorder (8388227-8)
on May 22, 2012 Male patient from BRAZIL , 60 years of age, was diagnosed with
- sinusitis (sinusitis Questions)
Pulmonary Eosinophilia, Weight Decreased, Chest Pain, Pyrexia (8386962-9)
Patient was taking Moxifloxacin (View Usage). Patient experienced the following unwanted or unexpected effects: pulmonary eosinophilia, weight decreased, chest pain (chest pain Questions), pyrexia on May 24, 2012 from UNITED KINGDOM Additional patient health information: Male patient , 27 years of age, weighting 141.1 lb, was diagnosed with
- tuberculosis (tuberculosis Questions)
Small Intestinal Obstruction, Diarrhoea, Condition Aggravated (8379103-5)
Adverse event was reported on May 22, 2012 by a Male patient taking Moxifloxacin (View Usage) (Dosage: 400 Mg Every Day Po) was diagnosed with
- upper respiratory tract infection
- bronchitis (bronchitis Questions)
Bone Marrow Failure, Leukopenia (8359463-1)
on May 14, 2012 Male patient from UNITED STATES , 65 years of age, weighting 185.6 lb, was diagnosed with
- infection (infection Questions)
Hypoacusis (8352962-8)
on May 09, 2012 Male patient from FRANCE , 40 years of age, was diagnosed with
- aspergillosis
Patient was taking other medications:
- VFEND (200 Mg, Qd) (View Vfend Review and Vfend Label )
- MYAMBUTOL (400 Mg, Bid) (View Myambutol Review and Myambutol Label )
- ISONIAZID (200 Mg, Qd) (View Isoniazid Review and Isoniazid Label )
Hyperglycaemia (8336796-6)
Patient was taking Moxifloxacin (View Usage). Patient had the following side effects: hyperglycaemia on Apr 24, 2012 from SPAIN Additional patient health information: Male patient , 43 years of age, . Moxifloxacin dosage: N/A.
Patient was taking other medications:
- ASPIRIN (View Aspirin Review and Aspirin Label )
- FOLIC ACID (View Folic Acid Review and Folic Acid Label )
- SEROQUEL (View Seroquel Review and Seroquel Label )
- RIFABUTIN (View Rifabutin Review and Rifabutin Label )
- ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label )
- OCTREOTIDE ACETATE (View Octreotide Acetate Review and Octreotide Acetate Label )
- CILOSTAZOL (View Cilostazol Review and Cilostazol Label )
- METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label )
Ear Infection, Clostridium Difficile Colitis (8322488-6)
Adverse event was reported on Apr 12, 2012 by a Female patient taking Moxifloxacin (View Usage) (Dosage: N/A) was diagnosed with
- ear infection (ear infection Questions)
Patient was taking other medications:
- COBALAMIN (View Cobalamin Review and Cobalamin Label )
- CALCIUM (View Calcium Review and Calcium Label )
- URSODIOL (View Ursodiol Review and Ursodiol Label )
- FIBER (View Fiber Review and Fiber Label )
- MUPIROCIN (OINTMENT) (View Mupirocin (ointment) Review and Mupirocin (ointment) Label )
- CALCIFEROL (View Calciferol Review and Calciferol Label )
- XYREM (View Xyrem Review and Xyrem Label )
Cognitive Disorder, Hallucination, Visual, Confusional State (8320714-0)
on Apr 26, 2012 Female patient from SPAIN , 85 years of age, was treated with Moxifloxacin (View Usage). Patient experienced the following unwanted or unexpected effects: cognitive disorder, hallucination, visual, confusional state. Moxifloxacin dosage: Unk.
Visual Acuity Reduced (8318000-8)
on Apr 17, 2012 Female patient from SOUTH AFRICA , weighting 85.10 lb, was diagnosed with
- pulmonary tuberculosis
Patient was taking other medications:
- RIFAMPICIN (Unk) (View Rifampicin Review and Rifampicin Label )
- ISONIAZID (Unk) (View Isoniazid Review and Isoniazid Label )
- PYRAZINAMIDE (Unk) (View Pyrazinamide Review and Pyrazinamide Label )
Torsade De Pointes, Hypokalaemia, Hypomagnesaemia (8310020-2)
Patient was taking Moxifloxacin Hcl (View Usage). After Moxifloxacin was administered, patient had the following side effects: torsade de pointes, hypokalaemia, hypomagnesaemia on Apr 11, 2012 from CANADA Additional patient health information: Male patient , 22 years of age, . Moxifloxacin Hcl dosage: N/A.
Patient was taking other medications:
- AZITHROMYCIN (View Azithromycin Review and Azithromycin Label )
Clostridium Difficile Colitis, Fall, Ear Infection, Ligament Rupture, Meniscus Lesion (8301828-8)
Adverse event was reported on Apr 05, 2012 by a Female patient taking Moxifloxacin (View Usage) (Dosage: N/A) was diagnosed with
- ear infection (ear infection Questions)
- sleep apnoea syndrome
Patient was taking other medications:
- XYREM (Oral, 9 Gm (4.5 Gm, 2 In 1 D) Oral) (View Xyrem Review and Xyrem Label )
Hepatotoxicity, Hepatic Fibrosis, Hepatitis Cholestatic, Pancreatic Duct Dilatation (8299343-3)
on Apr 16, 2012 Female patient from UNITED STATES , 46 years of age, was treated with Moxifloxacin (View Usage). Patient had the following side effects: hepatotoxicity, hepatic fibrosis, hepatitis cholestatic, pancreatic duct dilatation. Moxifloxacin dosage: N/A.
Electrocardiogram Qt Prolonged, Torsade De Pointes (8272288-0)
on Mar 26, 2012 Female patient from CANADA , 61 years of age, was treated with Moxifloxacin(View Usage). After Moxifloxacin was administered, patient had the following side effects: electrocardiogram qt prolonged, torsade de pointes. Moxifloxacin dosage: Unk.
Patient was taking other medications:
- FUROSEMIDE (Unk) (View Furosemide Review and Furosemide Label )
- HYDROCHLOROTHIAZIDE (Unk) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label )
Ventricular Arrhythmia, Hypokalaemia, Torsade De Pointes (8270433-4)
Patient was taking Moxifloxacin Hcl (View Usage). Patient experienced the following unwanted or unexpected effects: ventricular arrhythmia, hypokalaemia, torsade de pointes on Mar 24, 2012 from CANADA Additional patient health information: Female patient , 61 years of age, . Moxifloxacin Hcl dosage: N/A.
Patient was taking other medications:
- FUROSEMIDE (View Furosemide Review and Furosemide Label )
- HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label )
Torsade De Pointes, Blood Potassium Decreased, Electrocardiogram Qt Prolonged (8264721-5)
Adverse event was reported on Mar 26, 2012 by a Female patient taking Moxifloxacin (View Usage) (Dosage: N/A) . Location: ARGENTINA , 61 years of age, Patient had the following side effects: torsade de pointes, blood potassium decreased, electrocardiogram qt prolonged.
Patient was taking other medications:
- FUROSEMIDE (View Furosemide Review and Furosemide Label )
- HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label )
Endocarditis (8260481-2)
on Feb 16, 2012 Female patient from BELGIUM , 43 years of age, was diagnosed with
- antibiotic prophylaxis
Endophthalmitis, Iritis, Uveitis, Iridocyclitis, Vitritis, Retinal Haemorrhage (8248068-9)
on Mar 19, 2012 Male patient from JAPAN , 62 years of age, weighting 110.2 lb, was treated with Moxifloxacin Hydrochloride(View Usage). Patient experienced the following unwanted or unexpected effects: endophthalmitis, iritis, uveitis, iridocyclitis, vitritis, retinal haemorrhage. Moxifloxacin Hydrochloride dosage: N/A.
Patient was taking other medications:
- GATIFLOXACIN (View Gatifloxacin Review and Gatifloxacin Label )
- RANIBIZUMAB (View Ranibizumab Review and Ranibizumab Label )
Showing 1-25 of 655 Next Page >
Moxifloxacin Forum
had palpatations for about 2hr commencing aout 3hr after taking medication...Keep Reading
Moxifloxacin Adverse Effect Reports (FDA)
Moxifloxacin InformationSide Effects reported to FDA: 655. View FDA Adverse Reports Moxifloxacin safety alerts: No Reported deaths: 56 Reported hospitalizations: 195
| ||||||||||||||||||||||